Prime editing rescues osteogenic function of patient-derived iMSCs carrying the RUNX2 c.516delT mutation

Introduction Cleidocranial dysplasia (CCD) is a skeletal genetic disorder caused by RUNX2 mutation, for which no effective therapy is currently available. Prime editing (PE) enables precise insertion and deletion editing in mammalian cells, offering a promising approach for correcting heterozygous loss-of-function mutations. Methods Here, we applied PE to correct the RUNX2 c.516delT loss-of-function mutation in patient-derived induced mesenchymal stem cells (iMSCs). To improve editing efficiency, we employed mpknot-pegRNA and tevopreQ1-pegRNA designs in combination with PE2, PEmax, and PE7 variants. We then assessed the normalization of RUNX2 protein levels and downstream target activation upon gene correction. Results We achieved an editing efficiency of up to 30.6% in iMSCs. Following PE-mediated repair, the expression of RUNX2 downstream targets CBFβ and SP7 was significantly upregulated, and osteogenic differentiation and bone mineralization were partially rescued in mutant iMSCs. Discussion Collectively, our findings suggest that optimized prime editing systems can efficiently correct this pathogenic RUNX2 mutation in a patient-derived model and partially restore osteogenic function in vitro , providing a proof-of-concept for PE-based therapeutic strategies targeting this specific CCD-associated RUNX2 allele. Although further validation in additional patient samples and different mutation types is required, this study supports the potential of PE-based approaches for correction of loss-of-function frameshift mutations in CCD.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-12
DOI
https://doi.org/10.3389/fcell.2026.1957335
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prime editing rescues osteogenic function of patient-derived iMSCs carrying the RUNX2 c.516delT mutation

Xiaohua Jin, Hong‐Fei Xia, Chun-Yi Guan, Xiaofang Cao et al.
Frontiers in Cell and Developmental Biology
CRISPR and Genetic Engineering
article

Prime editing rescues osteogenic function of patient-derived iMSCs carrying the RUNX2 c.516delT mutation

Xiaohua Jin, Hong‐Fei Xia, Chun-Yi Guan, Xiaofang Cao, Xu Ma, Zi Chen, Zhi Ding, Lu Zhang, Hu Wang
article en

Abstract

Introduction Cleidocranial dysplasia (CCD) is a skeletal genetic disorder caused by RUNX2 mutation, for which no effective therapy is currently available. Prime editing (PE) enables precise insertion and deletion editing in mammalian cells, offering a promising approach for correcting heterozygous loss-of-function mutations. Methods Here, we applied PE to correct the RUNX2 c.516delT loss-of-function mutation in patient-derived induced mesenchymal stem cells (iMSCs). To improve editing efficiency, we employed mpknot-pegRNA and tevopreQ1-pegRNA designs in combination with PE2, PEmax, and PE7 variants. We then assessed the normalization of RUNX2 protein levels and downstream target activation upon gene correction. Results We achieved an editing efficiency of up to 30.6% in iMSCs. Following PE-mediated repair, the expression of RUNX2 downstream targets CBFβ and SP7 was significantly upregulated, and osteogenic differentiation and bone mineralization were partially rescued in mutant iMSCs. Discussion Collectively, our findings suggest that optimized prime editing systems can efficiently correct this pathogenic RUNX2 mutation in a patient-derived model and partially restore osteogenic function in vitro , providing a proof-of-concept for PE-based therapeutic strategies targeting this specific CCD-associated RUNX2 allele. Although further validation in additional patient samples and different mutation types is required, this study supports the potential of PE-based approaches for correction of loss-of-function frameshift mutations in CCD.

Frontiers in Cell and Developmental BiologyVol. 14
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
CRISPR and Genetic Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon